Freestone Capital Holdings, LLC Revance Therapeutics, Inc. Transaction History
Freestone Capital Holdings, LLC
- $2.9 Billion
- Q3 2024
A detailed history of Freestone Capital Holdings, LLC transactions in Revance Therapeutics, Inc. stock. As of the latest transaction made, Freestone Capital Holdings, LLC holds 18,020 shares of RVNC stock, worth $46,311. This represents 0.0% of its overall portfolio holdings.
Number of Shares
18,020Holding current value
$46,311% of portfolio
0.0%Shares
5 transactions
Others Institutions Holding RVNC
# of Institutions
230Shares Held
81.5MCall Options Held
617KPut Options Held
870K-
Black Rock Inc. New York, NY8.57MShares$22 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.73MShares$14.7 Million0.0% of portfolio
-
Franklin Resources Inc San Mateo, CA4.78MShares$12.3 Million0.0% of portfolio
-
Fil LTD Hamilton, D04.19MShares$10.8 Million0.01% of portfolio
-
Alpine Associates Management Inc. Englewood Cliffs, NJ4.16MShares$10.7 Million0.49% of portfolio
About Revance Therapeutics, Inc.
- Ticker RVNC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 82,305,696
- Market Cap $212M
- Description
- Revance Therapeutics, Inc., a biotechnology company, engages in the development, manufacture, and commercialization of neuromodulators for various aesthetic and therapeutic indications in the United States and internationally. The company's lead drug candidate is DaxibotulinumtoxinA for injection, which has completed phase III clinical trials fo...